Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: A SNP array-based linkage analysis of 38 families

Surgery

Volumn 146, Issue 6, 2009, Pages 1073-1080

  Suh, Insoo ^a   Filetti, Sebastiano ^c   Vriens, Menno R ^a   Guerrero, Marlon A ^a   Tumino, Salvatore ^d   Wong, Mariwil ^a   Shen, Wen T ^a   Kebebew, Electron ^a   Duh, Quan Yang ^a,b   Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 1Q; CHROMOSOME 6Q; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FAMILIAL NONMEDULLARY THYROID CANCER; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; GERM LINE; HUMAN; PEDIGREE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, PAPILLARY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID NEOPLASMS;

EID: 70549089107     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.012     Document Type: Article

References (25)

1. Grossman R.F., Tu S.H., Duh Q.Y., Siperstein A.E., Novosolov F., and Clark O.H. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130 (1995) 892-897
2. Loh K.C. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7 (1997) 107-113
3. Capezzone M., Marchisotta S., Cantara S., Busonero G., Brilli L., Pazaitou-Panayiotou K., et al. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15 (2008) 1075-1081
4. Alsanea O., Wada N., Ain K., Wong M., Taylor K., Ituarte P.H., et al. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128 (2000) 1043-1050
5. Sippel R.S., Caron N.R., and Clark O.H. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31 (2007) 924-933
6. Uchino S., Noguchi S., Kawamoto H., Yamashita H., Watanabe S., Yamashita H., et al. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26 (2002) 897-902
7. Kouvaraki M.A., Shapiro S.E., Perrier N.D., Cote G.J., Gagel R.F., Hoff A.O., et al. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15 (2005) 531-544
8. Malchoff C.D., and Malchoff D.M. Familial nonmedullary thyroid carcinoma. Cancer Control 13 (2006) 106-110
9. Canzian F., Amati P., Harach H.R., Kraimps J.L., Lesueur F., Barbier J., et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63 (1998) 1743-1748
10. Malchoff C.D., Sarfarazi M., Tendler B., Forouhar F., Whalen G., Joshi V., et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85 (2000) 1758-1764
11. McKay J.D., Lesueur F., Jonard L., Pastore A., Williamson J., Hoffman L., et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69 (2001) 440-446
12. Cavaco B.M., Batista P.F., Sobrinho L.G., and Leite V. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 93 (2008) 4426-4430
13. Abecasis G.R., Cherny S.S., Cookson W.O., and Cardon L.R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30 (2002) 97-101
14. Kong A., and Cox N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61 (1997) 1179-1188
15. Pal T., Vogl F.D., Chappuis P.O., Tsang R., Brierley J., Renard H., et al. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86 (2001) 5307-5312
16. Sturgeon C., and Clark O.H. Familial nonmedullary thyroid cancer. Thyroid 15 (2005) 588-593
17. Charkes N.D. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16 (2006) 181-186
18. Triponez F., Wong M., Sturgeon C., Caron N., Ginzinger D.G., Segal M.R., et al. Does familial non-medullary thyroid cancer adversely affect survival?. World J Surg 30 (2006) 787-793
19. Ma N.F., Hu L., Fung J.M., Xie D., Zheng B.J., Chen L., et al. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology 47 (2008) 503-510
20. Willis T.G., Zalcberg I.R., Coignet L.J., Wlodarska I., Stul M., Jadayel D.M., et al. Molecular cloning of translocation t(1;14) (q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 91 (1998) 1873-1881
21. Vandepoele K., Van Roy N., Staes K., Speleman F., and van Roy F. A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution. Mol Biol Evol 22 (2005) 2265-2274
22. Gudmundsson J., Sulem P., Gudbjartsson D.F., Jonasson J.G., Sigurdsson A., Bergthorsson J.T., et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41 (2009) 460-464
23. Brunaud L., Zarnegar R., Wada N., Magrane G., Wong M., Duh Q.Y., et al. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Thyroid 13 (2003) 621-629
24. Prazeres H.J., Rodrigues F., Soares P., Naidenov P., Figueiredo P., Campos B., et al. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7 (2008) 141-149
25. Xing M. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol (Oxf) 63 (2005) 263-266